This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesTrendsBuy This Stock CYAN vs. UPXI, IMCC, AKAN, BON, SMFL, CRON, CDXC, USNA, TLRY, and MNMDShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Upexi (UPXI), IM Cannabis (IMCC), Akanda (AKAN), Bon Natural Life (BON), Smart for Life (SMFL), Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Tilray (TLRY), and Mind Medicine (MindMed) (MNMD). These companies are all part of the "medicinals & botanicals" industry. Cyanotech vs. Upexi IM Cannabis Akanda Bon Natural Life Smart for Life Cronos Group ChromaDex USANA Health Sciences Tilray Mind Medicine (MindMed) Upexi (NASDAQ:UPXI) and Cyanotech (NASDAQ:CYAN) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk. Does the MarketBeat Community favor UPXI or CYAN? Cyanotech received 125 more outperform votes than Upexi when rated by MarketBeat users. Likewise, 63.68% of users gave Cyanotech an outperform vote while only 42.86% of users gave Upexi an outperform vote. CompanyUnderperformOutperformUpexiOutperform Votes342.86% Underperform Votes457.14% CyanotechOutperform Votes12863.68% Underperform Votes7336.32% Which has more risk and volatility, UPXI or CYAN? Upexi has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. Comparatively, Cyanotech has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Do institutionals and insiders believe in UPXI or CYAN? 5.7% of Upexi shares are held by institutional investors. Comparatively, 24.4% of Cyanotech shares are held by institutional investors. 34.7% of Upexi shares are held by insiders. Comparatively, 29.1% of Cyanotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher valuation & earnings, UPXI or CYAN? Cyanotech has higher revenue and earnings than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpexi$18.63M0.16-$23.66MN/AN/ACyanotech$23.07M0.10-$5.27M-$0.66-0.51 Is UPXI or CYAN more profitable? Upexi has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Upexi's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets UpexiN/A N/A N/A Cyanotech -19.50%-44.71%-19.12% Does the media prefer UPXI or CYAN? In the previous week, Upexi had 1 more articles in the media than Cyanotech. MarketBeat recorded 1 mentions for Upexi and 0 mentions for Cyanotech. Upexi's average media sentiment score of 1.00 beat Cyanotech's score of 0.00 indicating that Upexi is being referred to more favorably in the media. Company Overall Sentiment Upexi Positive Cyanotech Neutral SummaryUpexi beats Cyanotech on 8 of the 13 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.41M$1.18B$5.32B$7.35BDividend YieldN/AN/A5.47%4.34%P/E Ratio-0.5110.0421.9417.82Price / Sales0.109.44380.9597.73Price / CashN/A10.4038.3134.64Price / Book0.251.216.453.98Net Income-$5.27M-$56.07M$3.22B$247.81M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotechN/A$0.34+17.0%N/A-4.0%$2.41M$23.07M-0.5195Gap UpHigh Trading VolumeUPXIUpexi1.7474 of 5 stars$2.70+5.5%N/A-75.9%$3.57M$18.63M0.00130Short Interest ↓Positive NewsGap DownIMCCIM Cannabis0.3131 of 5 stars$1.37flatN/A-59.0%$3.06M$54.03M-0.40340Short Interest ↑AKANAkandaN/A$1.16+5.4%N/A-85.4%$1.66M$2.51M0.00110Positive NewsBONBon Natural LifeN/A$0.07-7.2%N/A-98.4%$281,000.00$23.84M0.00100Gap DownHigh Trading VolumeSMFLSmart for LifeN/A$0.00-27.8%N/A-100.0%$18,000.00$11.11M0.00110Gap DownCRONCronos Group1.5517 of 5 stars$1.72-1.7%$3.50+103.5%-25.3%$662.90M$117.62M-13.23450CDXCChromaDex2.849 of 5 starsN/A$9.03+∞N/A$611.50M$99.60M787.29120USNAUSANA Health Sciences4.763 of 5 stars$24.59-0.6%$36.00+46.4%-46.2%$464.87M$854.50M8.691,900Upcoming EarningsAnalyst RevisionTLRYTilray1.4256 of 5 stars$0.49-0.1%$1.92+293.7%-74.0%$456.45M$210.48M-1.622,650MNMDMind Medicine (MindMed)2.2949 of 5 stars$5.55+2.2%$25.11+352.5%-33.5%$409.25MN/A-2.4640Positive News Related Companies and Tools Related Companies UPXI Competitors IMCC Competitors AKAN Competitors BON Competitors SMFL Competitors CRON Competitors CDXC Competitors USNA Competitors TLRY Competitors MNMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
